Thrombotic thrombocytopenic purpura in a newborn

被引:15
作者
Paul T Jubinsky
Richard Moraille
Han-Mou Tsai
机构
[1] Div. Pediatric Hematology/Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461
[2] Division of Hematology/Oncology, Children's Hospital Medical Center, Cincinnati, OH
[3] Division of Neonatology, Children's Hospital Medical Center, Cincinnati, OH
[4] Division of Hematology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
基金
美国国家卫生研究院;
关键词
D O I
10.1038/sj.jp.7210853
中图分类号
学科分类号
摘要
The report describes a newborn who presented with hyperbilirubinemia and thrombocytopenia. The patient recovered after treatment with antibiotics, phototherapy, and a platelet transfusion. Analysis of the plasma von Willebrand factor-cleaving metalloprotease, ADAMTS13, revealed low protease activity in the patient and her two siblings, and a mild deficiency in both parents. These results confirmed the clinical suspicion of hereditary thrombotic thrombocytopenic purpura (TTP). Although most cases of thrombocytopenia and hyperbilirubinemia in the newborn period are caused by other causes, genetic deficiency of ADAMTS13 may not be as uncommon as previously believed. Early diagnosis may have important implications for the patients.
引用
收藏
页码:85 / 87
页数:2
相关论文
共 18 条
[1]  
Schulman I., Pierce M., Lukens A., Currimbhoy Z., Studies on thrombopoiesis: I. A factor in normal human plasma required for platelet production
[2]  
chronic thrombocytopenia due to its deficiency, Blood, 16, pp. 943-957, (1960)
[3]  
Upshaw J.D. Jr., Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia, N. Engl. J. Med., 298, pp. 1350-1352, (1978)
[4]  
Chintagumpala M.M., Hurwitz R.L., Moake J.L., Et al., Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission, J. Pediatr., 120, pp. 49-53, (1992)
[5]  
Nathanson S., Fremeaux-Bacchi V., Deschenes G., Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency, Pediatr. Nephrol., 16, pp. 554-556, (2001)
[6]  
Levy G.G., Nichols W.C., Lian E.C., Et al., Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura, Nature, 413, pp. 488-494, (2001)
[7]  
Furlan M., Robles R., Solenthaler M., Et al., Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura, Blood, 91, pp. 2839-2846, (1998)
[8]  
Furlan M., Robles R., Galbusera M., Et al., Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome, N. Engl. J. Med., 339, pp. 1578-1584, (1998)
[9]  
Tsai H.M., Lian E.C., Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura, N. Engl. J. Med., 339, pp. 1585-1594, (1998)
[10]  
Siedlecki C.A., Lestini B.J., Kottke-Marchant K.K., Et al., Shear-dependent changes in the three-dimensional structure of human von Willebrand factor, Blood, 88, pp. 2939-2950, (1996)